Multifrequency acoustics as a probe of mesoscopic blood coagulation dynamics by Ganesan, Adarsh et al.
1 
 
Multifrequency acoustics as a probe of mesoscopic blood coagulation dynamics 
Adarsh Ganesan1, Gokulnath Rajendran2, Ari Ercole2*, Ashwin Seshia1*$ 
1Nanoscience Centre, University of Cambridge, Cambridge CB3 0FF, UK. 
2Division of Anaesthesia, University of Cambridge, Cambridge CB2 0QQ, UK. 
*These authors contributed equally to the supervision of this project 
$Corresponding author 
 
Coagulation is a complex enzymatic polymerisation cascade. Disordered coagulation is common in 
medicine and may be life-threatening yet clinical assays are typically bulky and/or provide an 
incomplete picture of clot mechanical evolution. We present the adaptation of an in-plane acoustic 
wave device: quartz crystal microbalance with dissipation (QCM-D) at multiple harmonics to 
determine the time-evolution of mesoscale mechanical properties of clot formation in vitro. This 
approach is sensitive to changes in surface and bulk clot structure in various models of induced 
coagulopathy. Furthermore, we are able to show that clot formation at surfaces has different kinetics 
and mechanical strength to that in the bulk, which may have implications for the design of 
bioprosthetic materials. The ‘Multifrequency acoustics’ approach thus enables unique capability to 
portray biological processes concerning blood coagulation. 
 
Compound soft systems such as polymer solutions, melts, emulsions, gels and foams form a peculiar 
type of condensed matter where viscoelastic properties are controlled by the spatial arrangement of 
component filaments [1-6]. Coagulating blood is a highly complex heterogeneous, spatially and 
kinetically variable polymerising soft-system. In the face of initiation by injury, a complex system of 
prothrombotic enzymatic and cellular processes must rapidly propagate a clot by autocatalytic localised 
polymerisation and cellular interactions [7]. The mechanical properties of the clot are determined by the 
microstructural configuration and must be sufficiently strong to arrest bleeding [8]. Furthermore, a 
polymer degradation (“fibrinolysis”) pathway ensures that the clot does not persist inappropriately once 
tissue has been repaired. These competing processes and ultimate clot microstructure are exquisitely 
sensitive to initiation conditions and yet must be both quantitatively balanced and correctly temporally 
sequenced. Conventional laboratory assays for characterising coagulation disorders are based on 
primitive measurements of gelation time after clot initiation and poorly reflect in vivo coagulation 
kinetics and mechanical properties. More recent rheological methods such as thromboelastography 
(TEG) [9] measure clot strength but operate at clot mechanical shears that are not physiological and are 
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sensitive to millimetre length-scales which are far longer than the characteristic scales of clot 
microstructure. All of the current assays are flawed and so a better quantitative spatio-temporal 
characterization sensitive to mesoscopic clot properties would be of great clinical interest in diagnosis, 
resuscitation and in monitoring anticoagulation therapies. Furthermore, improved understanding of the 
interaction of coagulating blood and artificial surfaces can allow physicochemical design of materials 
with desirable pro- or antithrombotic surface properties for implant application.  
Here we attempt to characterize blood coagulation using information extracted from the Quartz Crystal 
Microbalance with Dissipation (QCM-D). QCM-D is an acoustic wave device and has been demonstrated 
to be sensitive to coagulation previously [10-14]. We extend the use of QCM-D to probe the coagulation 
using multiple harmonics of in-plane thickness-shear vibrations. The acoustic penetration depths in 
blood resulting from these in-plane waves depends on frequency and is of the order of 100nm and 
therefore comparable to the length of the fibrin monomer (around 40nm). Thus the acoustic probe 
presents a unique sensitivity to morphologically relevant mesoscopic length-scales which may be varied 
by studying the acoustic properties at different frequencies. To this end we modified the existing theory 
[15] to extract depth-dependent physical properties from the frequency dependence of QCM-D 
responses. 
Our QCM-D based mesoscopic characterization technique is based on the classical Stokes’ second flow 
problem that allows the quartz resonator to be just sensitive to a tiny region next to its surface (in the 
order of 100 nm for frequencies in tens of MHz and fluidic properties similar to water). As the fibrin 
clots, the frequency and energy dissipation of quartz resonant modes get modulated depending on the 
spatial distribution of clot density and rigidity in blood during clot organisation. We use the frequency 
dependent QCM-D technique to track depth dependent properties as a function of time for coagulation 
and fibrinolysis during natural and artificial conditions. The shifts in resonant frequency and energy 
dissipation of thickness shear waves due to the evolving physical properties of clot are given by [16] 
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(1) 
where 𝐸 and 𝜌 represent shear modulus and density of clot; 𝜅 is the shear stiffness between clot and 
quartz surface; 𝛿 is the Stokes length which is given by 𝛿 = √𝜂𝑙/(𝜌𝑙𝜋𝑓) where 𝜌𝑙 and 𝜂𝑙  are density and 
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viscosity of plasma. Using multi-frequency measurement, it is thus possible to track the underlying 
depth (𝛿)-dependent physical changes depending on trends observed in experiments. 
During coagulation on the QCM surface, there are fundamentally surface effects (including adhesion 
resulting from physicochemical interactions and surface initiation induced by enzymatic processes) and 
bulk effects (predominantly enzymatic). For the experimental validation of our method, four 
representative coagulation cascades exhibiting different degrees of surface and bulk effects during clot 
formation and lysis are considered viz. 1. ‘Initiated coagulation’ (representing ‘normal’ tissue-factor 
induced coagulation); 2. ‘Hyperfibrinolysis’ (an inappropriate activation of the fibrinolytic pathway that 
has been recently described after major haemorrhage but to which only TEG is sensitive); 3. 
‘Antagonised hyperfibrinolysis’ (representing the situation of treated hyperfibrinolysis and 
demonstrating the reversibility of changes to reversal of fibrinolysis) and 4. ‘Antagonised intrinsic 
fibrinolysis’ [16]. Condition 4 is of particular interest- there is evidence that administration of 
antifibrinolytic drugs improve survival after major haemorrhage but this must be given early [17]- the 
majority of such patients do not have a disorder of fibrinolysis as measured by conventional assays and 
therefore a mechanism for the effect of this drug in this context is unclear. Figure 1B and 1C shows the 
corresponding acoustic responses of QCM-D. Overall, the loading of QCM-D due to fibrin polymerization 
and clot solidification decreases the resonant frequency and increases the dissipation with time as 
previously reported in the literature [10-14]. During this measurement, temperature effects are not 
significant [16]. Hence, the modulation of acoustic responses can be solely attributed to the density and 
rigidity changes during clotting. Also, the other parameters such as surrounding liquid viscosity and pore 
size are only seen as correction factors for the absolute density of clot. That is, the clot density termed 
here, represents a collective average of actual density and pore size of clot and surrounding liquid 
viscosity. Using eq. (1), the temporal trends of clot density and rigidity that provide a measure of the 
complex interplay of physical processes are extracted [16]. 
In our experimental conditions that mimic the standard prothrombin time assay, tissue factor is present 
in excess and a phase change from liquid to gel is seen within <15 seconds). However it is clear that 
mechanical changes occur at longer timescales than this phase change presumably due to on-going 
crosslinking processes. Although the coagulation is ‘Tissue-factor initiated’ [16], our study provides an 
evidence for a dominant contact activation pathway in the mesoscopic region (Figure 2A) (cf [18]). This 
suggests that surface initiation is an important determinant of clot mechanical structure. Consequently, 
the clots formed near inert 2D gold surfaces have higher density.  
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In contrast to ‘Initiated coagulation’, the ‘antagonised intrinsic fibrinolysis’ case exhibits a spatially 
homogenous clot density in the bulk (Figure 2C). Intrinsic fibrinolysis is important, from the outset, in 
determining bulk clot density. Conventional clinical wisdom regards fibrinolysis as a late phenomenon 
related to clot breakdown [8], something that conventional assays have not been sensitive to. Our result 
suggests a mechanism for the beneficial effects of early administration of antifibrinolytics [17] even in 
patients in whom hyperfibrinolysis would not yet have occurred. Whilst states of uncontrolled 
hyperfibrinolysis do occur clinically with devastating effects on survival, these are relatively rare- for 
example after massive haemorrhage or transfusion. It is known administration of TxA to bleeding 
trauma patients [17] confers a survival benefit but this is only seen when given early- suggesting an 
effect that does not depend on the development of a hyperfibrinolytic state which occurs later and then 
only in a subset of patients. An effect of intrinsic fibrinolysis on early clot stability is therefore a plausible 
explanation for this and our assay is sensitive to such a process unlike conventional methods. Since 
antifibrinolytic therapy may also be associated with adverse outcome such as thromboembolic events 
that may be devastating, a more refined understanding of the role of fibrinolysis in the determination of 
clot structure is timely. In addition to antifibrinolytic effect, TxA may have complex dose-dependent 
effects on mesoscopic clot property kinetics (Figure 2D). 
During hyperfibrinolysis, the clot is broken down by tPA. This seems to be broadly similar to TEG. 
Interestingly, compared to figure 2A, even with hyperfibrinolysis, bulk clot density is higher. It is 
recognised that tPA may have some paradoxical early prothrombotic effects [19] which may explain our 
results although conventional clinical assays are not sensitive to this. Our study also suggests this early 
positive effect on bulk clot density during hyperfibrinolysis. Figure 2F also suggests that the 
hyperfibrinolysis is also involved in determining the stiffness of the interface properties. Presumably the 
interfacial layer becomes closer to the surface. Finally, the figure 2G shows that the ‘antagonised 
hyperfibrinolysis’ is just an intermediate between normal and hyperfibrinolysis indicating a partial 
reversal by TxA.  
In all of the coagulation studies, high rigidity surface (2D) layers and low rigidity bulk (3D weak structure) 
are associated with the clot microstructure. Further there is also evidence for a very stiff intermediate 
interlayer which has not been previously described. We propose this to be due to a transition region 
between surface (2D constrained) and bulk (free) polymerization structures (Figure 3).  
This technique clearly provides information that qualitatively replicates TEG but in a more robust and 
compact form-factor without macroscopically moving parts. Additionally, the sensitivity to surface and 
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bulk properties as a function of time give further information about clot mesoscopic properties and 
dynamics of clot formation as well as the interplay between multiple pro/antithrombotic pathways, 
interface effects and fibrinolysis. It is in principle straightforward to modify the QCM-D surface both 
chemically and physically (e.g. by nanoscale patterning) to obtain more insights into the physics of 
coagulation. The surface sensitivity of our method will prove useful in designing surface coatings with 
bespoke biological properties for example for bioprostheses. Further, the technique can be harnessed 
for evaluating the biocompatibility and toxicity of different materials to blood coagulation. Also, the 
lifetime of device utilizing our technique (such as QCM-D in our case) needs to be improved for practical 
application. 
This paper introduces a QCM-D based experimental technique to probe mesoscopic dynamics of blood 
coagulation. This study can be extended by probing the perturbations of higher harmonics (>7) for 
exploring the interface in greater detail. Our scalable technique can be readily implemented in tiny 
devices that are realized with custom acoustic properties using microfabrication and thin-film processing 
technologies. The underlying molecular level processes in the measured mesoscopic properties can also 
be studied through intense theoretical efforts. In this way, the technique has potential for the 
investigation of time-varying surface dependent mechanical effects in complex systems including 
protein aggregation and poly-gelation. For real world applications, universal to any metrology, the 
parameter being measured using our experimental technique based on QCM-D has to suffer minimal 
influence from the other parameters. 
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Figure 1: Scheme of acoustics aided spatial mapping: (a): Stokes flow is generated in the sample by the 
effect of thickness-shear vibrations of resonator. The corresponding damping length of this flow (𝛿) 
varies inversely with vibration frequency and therefore harmonic; (b) and (c): Resonant frequency shifts 
(panel (b)) and energy dissipation (panel (c)) against time for 3rd, 5th and 7th harmonics (15, 25 and 
35MHz respectively) during coagulation under different conditions. Initiated coagulation (plasma + TF), 
hyperfibrinolysis (plasma+tPA+TF), antagonised hyperfibrinolysis (plasma + tPA + TxA + TF), antagonised 
intrinsic fibrinolysis (plasma + TxA + TF). 
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Figure 2: Spatio-temporal map of clot density and rigidity during coagulation: Change in fractional clot 
density (
𝜌
𝜌𝑙
) (top panels) and fractional clot rigidity (
𝐸
𝜔0𝜂𝑙
) (bottom panels) for corresponding to (a-b) 
initiated coagulation (plasma + TF), (c-d) antagonised intrinsic fibrinolysis (plasma + TxA + TF), (e-f) 
hyperfibrinolysis (plasma + tPA + TF), (g-h) antagonised hyperfibrinolysis (plasma + tPA + TxA + TF) 
(Note: Green indicates baseline density in the figures A,C,E and G). 
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Figure 3: Cartoon representation of mesoscopic blood coagulation dynamics. Our results indicate a low 
rigidity bulk and intermediate rigidity surface layer are separated by an interlayer region of very high 
rigidity. We propose this to a result of the transition between 2D and 3D fibrin mesh properties. 
 
